Abstract LB460: Aberrant CRTC-CREB activation is required for the development and maintenance of LKB1-inactivated lung cancer - KIVIRID

Abstract LB460: Aberrant CRTC-CREB activation is required for the development and maintenance of LKB1-inactivated lung cancer

Authors: Xin Zhou, Wei Ni, Mu Yu, Xzaviar K. Solone, Yuping Sun, Lizi Wu

Published: 2025-04-25

DOI: 10.1158/1538-7445.am2025-lb460

Source: Full article

Abstract

Abstract